Bayer, Zydus extend pharma JV by 3 years
German chemical and pharma major Bayer and Ahmedabad-based Cadila Healthcare on Monday extended their pharmaceuticals joint venture by three years from June 2021. The companies...
Continue ReadingOvercoming the Challenges of API Complexity
Pharmaceutical drug molecules are becoming increasingly complex, posing challenges in formulation development and manufacturing. This is particularly true of small molecule drug APIs and peptides,...
Continue ReadingZydus Cadila, gets permission for clinical trials of antibodies cocktail to treat Covid-19
The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has been given permission...
Continue ReadingThis pharma firm in Gurugram first manufactured the drug that treats black fungus in India
While patients jostle to find the drug, Liposomal Amphotericin B, which treats black fungus, workers at Lifecare Innovations, a Gurugram-based pharmaceutical firm, have been working...
Continue ReadingBiological E’s Corbevax could be the most affordable Covid vaccine in India
Biological E’s Corbevax, which is undergoing Phase 3 trials, could well be the most affordable vaccine in India priced at below Rs 500 for two...
Continue ReadingPharmEasy acquires Medlife, becomes India’s largest e-pharma company
PharmEasy has acquired Medlife for an undisclosed amount, the e-pharmacy unicorn said on Tuesday. The deal will make PharmEasy the largest player in the domestic...
Continue ReadingIndia gives emergency use approval to Eli Lilly’s covid antibody drug
U.S. drugmaker Eli Lilly and Co today said its antibody drug combination has received an emergency use approval in India for the treatment of mild...
Continue ReadingGlenmark Pharma launches anti-epileptic drug, Rufinamide, in the US
Glenmark Pharma announced the launch of anti-epileptic drug Rufinamide tablets in the US market. Glenmark Pharmaceuticals Ltd has launched Rufinamide tablets USP in the strengths...
Continue ReadingBharat Biotech Dispatches Covaxin To 30 Cities In 1 Month; Eyes US Trials & WHO Approval
As the vaccination drive across the country continues, Bharat Biotech’s Covaxin has reached 30 cities, the Indian pharma giant announced. Bharat Biotech Co-founder and Joint...
Continue Reading